{"category": "spam", "to_address": "cruiseca@speedy.uwaterloo.ca", "from_address": "\"Stents Health Alert Newsletter\" <return@nicktalktime.com>", "subject": "Drug Coated Stents - Health Alert Newsletter", "body": "Drug Coated Stents \n- Health Alert Newsletter - April 14th, 2007 \nThe U.S. Food and Drug Administration, or FDA, cited studies \n  this week \n  showing drug-coated stent recipients face a significant blood-clot risk. \nThe makers of leading drug-coated stents include Johnson & \n  Johnson, \n  Cypher Drug Coated Stents and Boston Scientific, Taxus Extreme Drug Coated Stents. \n  \nDrug-coated stents have been placed in about 6 million people \n  worldwide. \nIf \n  you or someone you know has had a drug-coated stent implanted they may be at \n  risk. \nIf so, you or that someone may be entitled to monetary damages.\n\n\n\n\n\n\n\n\n\n---------------------------------------------------------------\nTo \n  stop receiving announcements about Drug Coated Stents\nUHaveALawyer\n  3 Bethesda Metro Center, Suite 110\n  Bethesda, MD. 20814\nUHaveALawyer is not associated with \n  Johnson & Johnson or Boston Scientific.  \n\n\n______________________________________________________\n\n\n\n"}